市場調查報告書
商品編碼
1410859
全球人工心臟瓣膜市場 - 市場規模(按細分市場)、份額、監管、報銷、治療、預測(~2033 年)Prosthetic Heart Valves Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
世界上老年人口的不斷增長以及心臟瓣膜疾病的相應增加是人造心臟瓣膜市場的主要驅動因素。 瓣膜性心臟病的盛行率隨著年齡的增長而增加。 全球有超過 1 億人受到瓣膜性心臟病的影響,包括瓣膜狹窄和瓣膜逆流。
本報告研究和分析了全球人造心臟瓣膜市場,並提供了有關每個細分市場的市場規模、市場趨勢、競爭格局以及 COVID-19 影響的資訊。
市場模型的主要內容如下。
人工心臟瓣膜已經上市以及不斷變化的競爭格局
全球、區域和國家層面的特定市場考量
透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息,使您能夠更深入地研究市場動態。
目標公司
Prosthetic Heart Valves Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Prosthetic Heart Valves market for the year 2020 and beyond. Increase in aging population across the globe and the associated valvular degeneration is a major driving factor of the Prosthetic Heart Valve market. Prevalence of valvular heart diseases increases with the age. Globally over 100 million people are affected by Valvular Heart Diseases including cases Valve Stenosis and Regurgitation. Depending on the severity of the condition Valvular Heart Diseases can be treated by surgical repair or replacement procedures using prosthetic heart valves. Mechanical heart valves are generally made of non-physiological materials with a mobile occluder, which is made of rigid materials. This segment comprises of Mechanical Sutured Mitral Valve Replacements and Mechanical Sutured Aortic Valve Replacements.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Prosthetic Heart Valves market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, Braile Biomedica Ltda, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable